TCT 473: Reproducibility of Cusp Overlap Technique to Reduce Permanent Pacemaker Implantation With Evolut – The Latin American Experience

TCT 486: The Impact of Atrial Fibrillation on the In-Hospital Outcomes After Aortic Valve Replacement

TCT 466: New Pacemaker Implantation Following Transcatheter Aortic Valve Replacement

TCT 487: MIDAS has Only Trivial Impact on PPM Implantation Using the Largest Self-Expandable TAVR-Device

TCT 463: Computed Tomography Angiography-Fluoroscopy Fusion Imaging for the Guidance of Cerebral Embolic Protection Deployment During Transcatheter Aortic Valve Replacement

TCT 465: Implantation Characteristics and Development of Hypoattenuated Leaflet Thickening in Low Risk Patients undergoing Transcatheter Aortic Valve Replacement

TCT 484: Inclusion of Very Small Cerebral Lesions in Quantitative Embolic Protection Study Endpoints May Obscure Clinical Relevance 

TCT 470: Novel Method for Implantation of Balloon Expandable Transcatheter Aortic Valve Replacement to Reduce Pacemaker Rate - Line of Lucency Method

TCT 456: Determining the Association Between Prosthesis Geometry and Leaflet Thrombosis (LT) Following Transcatheter Aortic Valve Replacement (TAVR)

TCT 475: In Tavi the Less Antibiotics, the Better!